Published in Appl Environ Microbiol on September 01, 1982
Initial-phase optimization for bioremediation of munition compound-contaminated soils. Appl Environ Microbiol (1993) 2.24
Construction of a Pseudomonas hybrid strain that mineralizes 2,4,6-trinitrotoluene. J Bacteriol (1993) 1.80
Biological degradation of 2,4,6-trinitrotoluene. Microbiol Mol Biol Rev (2001) 1.58
Identification of a hydride-Meisenheimer complex as a metabolite of 2,4,6-trinitrotoluene by a Mycobacterium strain. J Bacteriol (1994) 1.46
Transformation of 2,4,6-Trinitrotoluene by Pseudomonas pseudoalcaligenes JS52. Appl Environ Microbiol (1997) 1.13
Microbial transformation of nitroaromatics in surface soils and aquifer materials. Appl Environ Microbiol (1994) 1.08
Characterization of metabolites in the biotransformation of 2,4,6-trinitrotoluene with anaerobic sludge: role of triaminotoluene. Appl Environ Microbiol (1998) 0.93
Biotransformation of 2,4,6-trinitrotoluene with Phanerochaete chrysosporium in agitated cultures at pH 4.5. Appl Environ Microbiol (1999) 0.89
Transformation of 2,4,6-trinitrotoluene (TNT) by actinomycetes isolated from TNT-contaminated and uncontaminated environments. Appl Environ Microbiol (1996) 0.83
Microbial transformation of 2,4,6-trinitrotoluene in aerobic soil columns. Appl Environ Microbiol (1996) 0.79
Structure of a laccase-mediated product of coupling of 2,4-diamino-6-nitrotoluene to guaiacol, a model for coupling of 2,4,6-trinitrotoluene metabolites to a humic organic soil matrix. Appl Environ Microbiol (1997) 0.76
Microbial transformation of 2,4,6-trinitrotoluene and other nitroaromatic compounds. Appl Environ Microbiol (1976) 4.20
Toxicity and mutagenicity of 2,4,-6-trinitrotoluene and its microbial metabolites. Appl Environ Microbiol (1976) 2.13
Microbial transformation of 14C-labeled 2,4,6-trinitrotoluene in an activated-sludge system. Appl Environ Microbiol (1978) 2.04
Biological treatability of trinitrotoluene manufacturing wastewater. J Water Pollut Control Fed (1974) 1.57
Isolation and characterization of TNT and its metabolites in groundwater by gas chromatograph-mass spectrometer-computer techniques. Bull Environ Contam Toxicol (1979) 1.08
Mutagenicity of 2,4,6-trinitrotoluene-surfactant complexes. Bull Environ Contam Toxicol (1982) 0.97
Synthesis and properties of antiprotein antibodies of sheep: secondary antibody response. Am J Vet Res (1972) 6.26
Neonatal salmonella meningitis complicated by cerebral abscesses. West J Med (1977) 5.55
Functionalized silk-based biomaterials for bone formation. J Biomed Mater Res (2001) 3.26
Intramuscular injections in children. Pediatrics (1982) 2.43
Biodegradation of hexahydro-1,3,5-trinitro-1,3,5-triazine. Appl Environ Microbiol (1981) 2.31
Identification of biotransformation products from 2,4-dinitrotoluene. Appl Environ Microbiol (1978) 2.07
Microbial transformation of 14C-labeled 2,4,6-trinitrotoluene in an activated-sludge system. Appl Environ Microbiol (1978) 2.04
Biblical leprosy: an anachronism whose time has come. J Am Acad Dermatol (1993) 2.01
Lack of association between bacteriuria and symptoms in the elderly. Am J Med (1986) 1.85
Bacterial cellulose as a potential scaffold for tissue engineering of cartilage. Biomaterials (2005) 1.75
Silk fibroin as an organic polymer for controlled drug delivery. J Control Release (2006) 1.71
Construction, cloning, and expression of synthetic genes encoding spider dragline silk. Biochemistry (1995) 1.59
Macrophage regulation of mitogen-induced blastogenesis. I. Demonstration of inhibitory cells in the spleens and peritoneal exudates of mice. Cell Immunol (1977) 1.45
Primary amoebic meningoencephalitis with Naegleria fowleri: clinical review. Pediatr Neurol (1996) 1.44
Microbial degradation of glycerol nitrates. Appl Environ Microbiol (1978) 1.43
Fungal susceptibility of polyurethanes. Appl Microbiol (1968) 1.41
Hyperfractionated radiation therapy (72 Gy) for children with brain stem gliomas. A Childrens Cancer Group Phase I/II Trial. Cancer (1993) 1.40
Silk based biomaterials to heal critical sized femur defects. Bone (2006) 1.40
T cell independence of bleomycin-induced pulmonary fibrosis. J Leukoc Biol (1999) 1.39
Induction of macrophage-mediated tumor-cell cytotoxicity by pyran copolymer. J Natl Cancer Inst (1974) 1.23
Expression of a new cell surface antigen on activated murine macrophages. J Exp Med (1977) 1.21
Spectrum of ovine immunoglobulins. Proc Soc Exp Biol Med (1968) 1.19
Mechanical stimulation promotes osteogenic differentiation of human bone marrow stromal cells on 3-D partially demineralized bone scaffolds in vitro. Calcif Tissue Int (2004) 1.18
Controlling beta-sheet assembly in genetically engineered silk by enzymatic phosphorylation/dephosphorylation. Biochemistry (2000) 1.17
Surface organization and nanopatterning of collagen by dip-pen nanolithography. Proc Natl Acad Sci U S A (2001) 1.12
Outcome of children with brain stem gliomas after treatment with 7800 cGy of hyperfractionated radiotherapy. A Childrens Cancer Group Phase I/II Trial. Cancer (1994) 1.11
Molecular biology of spider silk. J Biotechnol (2000) 1.11
The role of macrophages in wound repair: a review. Plast Reconstr Surg (1981) 1.10
Biofunctionalized electrospun silk mats as a topical bioactive dressing for accelerated wound healing. Acta Biomater (2008) 1.08
Reduction-oxidation control of beta-sheet assembly in genetically engineered silk. Biomacromolecules (2000) 1.05
Macrophage regulation of mitogen-induced blastogenesis. II. Mechanism of inhibition. Cell Immunol (1977) 1.04
Bleomycin-induced pulmonary fibrosis is independent of eosinophils. J Leukoc Biol (2000) 1.03
A biotinylated undecylthiophene copolymer bioconjugate for surface immobilization: creating an alkaline phosphatase chemiluminescence-based biosensor. Bioconjug Chem (1996) 1.01
A new approach for containment of microorganisms: dual control of streptavidin expression by antisense RNA and the T7 transcription system. Proc Natl Acad Sci U S A (1997) 1.01
Granulocyte colony-stimulating factor crosses the placenta and stimulates fetal rat granulopoiesis. Blood (1993) 1.00
Aplasia cutis congenita complicated by sagittal sinus hemorrhage. Pediatrics (1980) 0.99
High dose chemotherapy with autologous bone marrow rescue for children with diffuse pontine brain stem tumors. Children's Cancer Group. J Neurooncol (1998) 0.97
Mutagenicity of 2,4,6-trinitrotoluene-surfactant complexes. Bull Environ Contam Toxicol (1982) 0.97
Familial porencephaly. Arch Neurol (1983) 0.96
Biodegradation of glycidol and glycidyl nitrate. Appl Environ Microbiol (1982) 0.96
Reducing maltreated children's reluctance to answer hypothetical oath-taking competency questions. Law Hum Behav (2001) 0.94
Relationship of expression of A cell-surface antigen on activated murine macrophages to tumor cell cytotoxicity. J Immunol (1978) 0.94
Friedreich's ataxia with acute cardiomyopathy. Am J Dis Child (1980) 0.93
Inhibition of host resistance by nutritional hypercholesteremia. Infect Immun (1979) 0.93
Biosynthesis of novel exopolymers by Aureobasidium pullulans. Appl Environ Microbiol (1999) 0.93
Pityriasis amiantacea: a report of 10 cases. Arch Dermatol (1993) 0.92
Macrophage activation and anti-tumor activity of biologic and synthetic agents. Int J Cancer (1976) 0.91
Molecular weight distribution of chitosan isolated from Mucor rouxii under different culture and processing conditions. Biotechnol Bioeng (1992) 0.91
Immunologic alterations in bleomycin-treated mice: role of pulmonary fibrosis in the modulation of immune responses. Am J Respir Crit Care Med (1996) 0.91
Biosynthesis of emulsan biopolymers from agro-based feedstocks. J Appl Microbiol (2007) 0.90
Encephalitis associated with carcinoma. Central hypoventilation syndrome and cytoplasmic inclusion bodies. J Neurol Neurosurg Psychiatry (1974) 0.90
T-lymphocyte heterogeneity in the rat: separation of distinct rat T-lymphocyte populations which respond in syngeneic and allogeneic mixed lymphocyte reactions. Cell Immunol (1984) 0.90
Immunologic tolerance to HGG in mice. I. Suppression of the HGG response in normal mice with spleen cells or a spleen cell lysate from tolerant mice. J Immunol (1977) 0.90
VEGF and BMP-2 promote bone regeneration by facilitating bone marrow stem cell homing and differentiation. Eur Cell Mater (2014) 0.90
The requirement for surface Ig signaling as a prerequisite for T cell:B cell interactions. A possible role for desialylation. J Immunol (1988) 0.89
The oral-facial-digital syndromes reviewed: the role of computerized axial tomography in management. Ariz Med (1980) 0.89
Inhibition of cell-mediated immunity in patients with brain tumors. Surg Neurol (1976) 0.89
Idiopathic pneumonia syndrome after allogeneic bone marrow transplantation in mice. Role of pretransplant radiation conditioning. Am J Respir Cell Mol Biol (1999) 0.88
Serum interleukin-1 (IL-1) activity in alcoholic hepatitis. Life Sci (1986) 0.88
Malignant hyperthermia associated with myopathy and normal muscle enzymes. J Pediatr (1977) 0.88
Cellular aspects of tolerance. II. Unresponsiveness of B cells. Cell Immunol (1973) 0.88
Macrophage mediated tumor cell cytotoxicity. Ann N Y Acad Sci (1976) 0.87
T-deficient transmembrane signaling in CD4+ T cells of retroviral-induced immune-deficient mice. J Immunol (1992) 0.87
Identification of a macrophage-specific cell surface antigen. J Immunol (1976) 0.87
High-dose carmustine, thiotepa and etoposide followed by autologous bone marrow rescue for the treatment of high risk central nervous system tumors. Bone Marrow Transplant (2000) 0.86
Eating style of obese and nonobese males. Psychosom Med (1980) 0.86
Characterization and function of autoreactive T-lymphocyte clones isolated from normal, unprimed mice. Cell Immunol (1985) 0.86
Bioengineering of emulsifier structure: emulsan analogs. Can J Microbiol (1997) 0.86
Meningeal sarcoma of the spinal cord in a newborn. Arch Neurol (1978) 0.86
Biodegradation of N-nitrosodimethylamine in aqueous and soil systems. Appl Environ Microbiol (1985) 0.86
Adherent Ia+ murine tumor lines with characteristics of dendritic cells. I. Morphology, surface phenotype, and induction of syngeneic mixed lymphocyte reactions. J Exp Med (1981) 0.86
Human mononuclear phagocyte-associated antigens. II. Lymphokine-inducible antigens on the macrophage cell line, U937. Cell Immunol (1981) 0.86
Antigen presentation in the rat. II. An Ia+ radiosensitive T cell can present antigen to primed Ia- T cells. J Immunol (1985) 0.85
Differential requirement for accessory cells in polyclonal T-cell activation. Cell Immunol (1987) 0.85
Antigen presentation in the rat: role of a nonadherent, nonphagocytic, W3/13, OX-6 positive T cell in the presentation of antigen to primed T lymphocytes. Cell Immunol (1984) 0.85
Primary antibody responses to thymus-independent antigens in the lungs and hilar lymph nodes of mice. Infect Immun (1990) 0.85
Serological characterization of antibodies eluted from chronically rejected human renal allografts. Transplantation (1981) 0.85
Cellular basis of decreased immune responses to pneumococcal vaccines in aged mice. Infect Immun (1996) 0.85
Immunoregulation in the rat: characteristics of a suppressor T cell that inhibits antigen-dependent cell proliferation. J Immunol (1985) 0.85
Controllable transition of silk fibroin nanostructures: an insight into in vitro silk self-assembly process. Acta Biomater (2013) 0.85
Role of virus replication in a murine model of AIDS-associated interstitial pneumonitis. Exp Lung Res (1999) 0.84
Heterogeneity in direct cytotoxic function of L3T4 T cells. TH1 clones express higher cytotoxic activity to antigen-presenting cells than TH2 clones. J Immunol (1990) 0.84
Induction of a syngeneic graft-versus-host disease-like syndrome in DBA/2 mice. Transplantation (1989) 0.84
Eruptive pruritic papules. Eruptive syringomas (eruptive hidradenomas of Jacquet and Darier). Arch Dermatol (1989) 0.84
Human mononuclear phagocyte-associated antigens. III. Relationship of cell surface antigen phenotype between cultured monocytes and tissue macrophages. J Reticuloendothel Soc (1983) 0.83
Activation-dependent apoptosis in CD4+ T cells during murine AIDS. Cell Immunol (1993) 0.83
Maternal administration of granulocyte colony-stimulating factor improves neonatal rat survival after a lethal group B streptococcal infection. Blood (1993) 0.83
Direct incorporation of glucosamine and N-acetylglucosamine into exopolymers by Gluconacetobacter xylinus (=Acetobacter xylinum) ATCC 10245: production of chitosan-cellulose and chitin-cellulose exopolymers. Appl Environ Microbiol (2001) 0.83
Integration of silk protein in organic and light-emitting transistors. Org Electron (2011) 0.83
Cytotoxicity to tumor cells of monocytes from normal individuals and cancer patients. Int J Cancer (1980) 0.82
Occurrence of ovine homocytotropic antibody. Proc Soc Exp Biol Med (1969) 0.82
Pulmonary lymphoid cell activation and cytokine expression in murine AIDS-associated interstitial pneumonitis. Am J Respir Cell Mol Biol (1997) 0.82
The affliction of Job: poisoned! J Am Acad Dermatol (1999) 0.82
Contribution of T lymphocytes to the development of bleomycin-induced pulmonary fibrosis. Ann N Y Acad Sci (1996) 0.82
Induction of syngeneic graft-versus-host disease in LPS hyporesponsive C3H/HeJ mice. J Leukoc Biol (2001) 0.82
Dietary hepatic cholesterol elevation: effects on coxsackievirus B infection and inflammation. Infect Immun (1982) 0.82
Cellular basis of differential responsiveness of lymph nodes and spleen to 23-valent Pnu-Imune vaccine. J Immunol (1994) 0.82
Two-photon-induced fluorescence from the phycoerythrin protein. Appl Opt (1997) 0.82
Inhibition of graft-versus-host disease. Use of a T cell-controlled suicide gene. J Immunol (1997) 0.81